Mankind Pharma

Delhi, India Founded: 1991 • Age: 35 yrs
Pharmaceutical company engaged in developing, manufacturing, and marketing a diverse range of pharmaceutical formulations
Request Access

About Mankind Pharma

Mankind Pharma is a company based in Delhi (India) founded in 1991 by Greesh Juneja, Ramesh Chand Juneja, Ramesh Juneja, and Rajeev Juneja.. Mankind Pharma has raised $367.2 million across 2 funding rounds from investors including ChrysCapital and Monet. The company has 21,320 employees as of March 31, 2024. Mankind Pharma has completed 2 acquisitions, including BSV Group and Upakarma. Mankind Pharma offers products and services including Formulations and Consumer Healthcare Products.

  • Headquarter Delhi, India
  • Employees 21320 as on 31 Mar, 2024
  • Founders Greesh Juneja, Ramesh Chand Juneja, Ramesh Juneja, Rajeev Juneja
  • Stage Public
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Mankind Pharma Ltd.
Operational Areas
Healthcare → Pharmaceuticals & Therapeutics
Key Metrics
  • Annual Revenue
    $1.43 B (USD)
    18.99
    as on Mar 31, 2024
  • Net Profit
    $232.59 M (USD)
    4.08
    as on Mar 31, 2024
  • EBITDA
    $362.27 M (USD)
    21.13
    as on Mar 31, 2024
  • Total Equity Funding
    $367.2 M (USD)

    in 2 rounds

  • Latest Funding Round
    $350 M (USD), Private Equity Round

    Apr 02, 2018

  • Investors
  • Employee Count
    21320

    as on Mar 31, 2024

  • Investments & Acquisitions
    BSV Group

    & 1 more

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

IPO & Listings of Mankind Pharma

Mankind Pharma is a publicly listed company on the NSE with ticker symbol MANKIND in India, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.

Exchange: NSE · Ticker: MANKIND . Sector: Health technology · India

Products & Services of Mankind Pharma

Mankind Pharma offers a comprehensive portfolio of products and services, including Formulations and Consumer Healthcare Products. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

A range of pharmaceutical formulations across acute and chronic therapeutic areas is developed and marketed to address patient needs.

Products for the non-prescription segment, such as antacids and condoms, are offered to meet everyday healthcare requirements.

People of Mankind Pharma
Headcount 10000+
Employee Profiles 139
Board Members and Advisors 1
Employee Profiles
People
Anish Tegta
Senior Human Resources Officer
People
Dr.taj Shinwari
Business Unit Head
People
Prateek Pathak
Office Administration Manager
People
Dr. Chhavi Sandhu
Assistant General Manager

Unlock access to complete

Funding Insights of Mankind Pharma

Mankind Pharma has successfully raised a total of $367.2M across 2 strategic funding rounds. The most recent funding activity was a Private Equity Round round of $350 million completed in April 2018. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 2
  • Last Round Private Equity Round — $350.0M
  • First Round

    (23 Apr 2007)

  • Investors Count 2
Date Amount Transaction Name Valuation Lead Investors Investors
Apr, 2018 Amount Private Equity Round - Mankind Pharma Valuation ChrysCapital
Apr, 2007 Amount Series A - Mankind Pharma Valuation Monet
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Mankind Pharma

Mankind Pharma has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include ChrysCapital and Monet. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
Investment firm focusing on private equity in sectors like financial services and healthcare.
Founded Year Domain Location
-
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Mankind Pharma

Mankind Pharma has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include BSV Group and Upakarma. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Acquisitions
Company Name Description Domain Location Founded Year Amount
Internet first D2C brand offering ayurvedic health, beauty, immunity & wellness products
2017
Provider of drug research & development services for pharmaceutical sector
1971
Company Name Description Domain Location Founded Year Amount
OVO is recognized as a smart digital payment application.
2017
Bionic investment advisor platform
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014

Financial Statements - Mankind Pharma

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Mankind Pharma Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Mankind Pharma

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Mankind Pharma

Frequently Asked Questions about Mankind Pharma

When was Mankind Pharma founded?

Mankind Pharma was founded in 1991 and raised its 1st funding round 16 years after it was founded.

Where is Mankind Pharma located?

Mankind Pharma is headquartered in Delhi, India. It is registered at Delhi, Delhi, India.

Who is the current CEO of Mankind Pharma?

Sheetal Arora is the current CEO of Mankind Pharma.

Is Mankind Pharma a funded company?

Mankind Pharma is a funded company, having raised a total of $367.2M across 2 funding rounds to date. The company's 1st funding round was a Series A of $17.2M, raised on Apr 23, 2007.

How many employees does Mankind Pharma have?

As of Mar 31, 2024, the latest employee count at Mankind Pharma is 21,320.

What is the annual revenue of Mankind Pharma?

Annual revenue of Mankind Pharma is $1.43B as on Mar 31, 2024.

What does Mankind Pharma do?

Established in 1991 and headquartered in Delhi, India, the pharmaceutical company is involved in the development, manufacturing, and marketing of formulations targeting multiple therapeutic areas. These include anti-infectives, cardiovascular, gastrointestinal, respiratory, vitamins, minerals, nutrients, anti-diabetic, neurocentral nervous system, and gynaecology segments. Both acute and chronic conditions are addressed through brands such as Nurokind, Telmikind, Moxikind, Amlokind, and Gudcef.

What products or services does Mankind Pharma offer?

Mankind Pharma offers Formulations and Consumer Healthcare Products.

Is Mankind Pharma publicly traded?

Yes, Mankind Pharma is publicly traded on NSE under the ticker symbol MANKIND.

How many acquisitions has Mankind Pharma made?

Mankind Pharma has made 2 acquisitions, including BSV Group, and Upakarma.

Who are Mankind Pharma's investors?

Mankind Pharma has 2 investors. Key investors include ChrysCapital, and Monet.

What is Mankind Pharma's ticker symbol?

The ticker symbol of Mankind Pharma is MANKIND on NSE.

What is Mankind Pharma's valuation?

The valuation of Mankind Pharma is $216.5M as of Apr 2007.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available